All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The large envelope protein exists in two topological conformations, one which is termed 'external' or Le-HBsAg and the other 'internal' or Li-HBsAg. In its external conformation the protein attaches the virus to cell receptors and thereby initiating infection. This interaction determines the species specificity and liver tropism. This attachment induces virion internalization predominantly through caveolin-mediated endocytosis. The large envelope protein also assumes fusion between virion membrane and endosomal membrane (Probable). In its internal conformation the protein plays a role in virion morphogenesis and mediates the contact with the nucleocapsid like a matrix protein.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-T-1-M319-2 | Anti-HBV S protein scFv h(CD28) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD28 | Lentiviral | T cell | ||
CAR-T-1-M319-G | Anti-HBV S protein scFv h(FcεRIγ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-FcεRIγ | Lentiviral | T cell | ||
CAR-T-1-M319-Z | Anti-HBV S protein scFv h(CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M319-2G | Anti-HBV S protein scFv h(CD28-FcεRIγ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD28-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-M319-2Z | Anti-HBV S protein scFv h(CD28-CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD28-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M319-4G | Anti-HBV S protein scFv h(CD4-FcεRIγ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD4-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-M319-4Z | Anti-HBV S protein scFv h(CD4-CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD4-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M319-8Z | Anti-HBV S protein scFv h(CD8-CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD8-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M319-BZ | Anti-HBV S protein scFv h(41BB-CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M319-CZ | Anti-HBV S protein scFv h(b2c-CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-b2c-CD3ζ | Lentiviral | T cell | ||
CAR-T-3-M319-2BZ | Anti-HBV S protein scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-3-M319-2XZ | Anti-HBV S protein scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1 | Human | S 26 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION